ID   FEMX-I/SUPER1618
AC   CVCL_F1B1
RX   PubMed=18802032;
CC   Doubling time: 17 hours (PubMed=18802032).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:9454; PROM1.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A011 ! FEMX-I
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
RX   PubMed=18802032; DOI=10.1634/stemcells.2008-0601; PMCID=PMC2713505;
RA   Rappa, Germana
RA   Fodstad, Oystein
RA   Lorico, Aurelio
RT   "The stem cell-associated antigen CD133 (Prominin-1) is a molecular
RT   therapeutic target for metastatic melanoma.";
RL   Stem Cells 26:3008-3017(2008).
//